{"id":198,"date":"2013-02-21T10:52:37","date_gmt":"2013-02-21T01:52:37","guid":{"rendered":"http:\/\/mus36.rbrc.jp:8162\/?page_id=198"},"modified":"2026-06-30T09:44:42","modified_gmt":"2026-06-30T00:44:42","slug":"mouse_of_month","status":"publish","type":"page","link":"http:\/\/mus.brc.riken.jp\/ja\/mouse_of_month","title":{"rendered":"\u4eca\u6708\u306e\u30de\u30a6\u30b9\u30fb\u30d0\u30c3\u30af\u30ca\u30f3\u30d0\u30fc"},"content":{"rendered":"
\n

<\/a><\/p>\n

2026<\/h3>\n
\n
\n

Jun 2026
\n \u984e\u9854\u9762\u9aa8\u5f62\u6210\u4e0d\u5168\u75c7\u30e2\u30c7\u30eb\u30de\u30a6\u30b9<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Apr 2026
\n \u30ec\u30e0\u7761\u7720\u306b\u95a2\u308f\u308bCrhbp<\/i>\u907a\u4f1d\u5b50<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n<\/div>\n

<\/a><\/p>\n

2025<\/h3>\n
\n
\n

Apr 2025
\n Recql5<\/i> \u907a\u4f1d\u5b50\u5909\u7570\u30de\u30a6\u30b9\u3092\u7528\u3044\u305f\u67d3\u8272\u4f53\u65ad\u7247\u5316\u5f8c\u518d\u5408\u6210\u306e\u8a98\u767a<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n<\/div>\n

<\/a><\/p>\n

2024<\/h3>\n
\n
\n

Dec 2024
\n \u751f\u4f53\u5185\u30bf\u30f3\u30d1\u30af\u8cea\u9593\u76f8\u4e92\u4f5c\u7528\u3092\u89e3\u6790\u53ef\u80fd\u306ain vivo<\/i> BioID\u30de\u30a6\u30b9
\n<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Apr 2024
\n CD103\u967d\u6027\u6a39\u72b6\u7d30\u80de\u3068\u6d88\u5316\u7ba1\u7c98\u819c\u514d\u75ab\u5bdb\u5bb9\u306e\u95a2\u4fc2\u6027
\n<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Mar 2024
\n \u65b0\u898f\u30d7\u30ed\u30fc\u30d6\u3092\u7528\u3044\u305f\u3001\u795e\u7d4c\u7d30\u80de\u306b\u304a\u3051\u308b\u30db\u30e2\u30d5\u30a3\u30ea\u30c3\u30af\u76f8\u4e92\u4f5c\u7528\u306e\u53ef\u8996\u5316
\n<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Jan 2024
\n \u30a8\u30e1\u30e9\u30eb\u30c9\u30eb\u30b7\u30d5\u30a7\u30e9\u30fc\u30bc\u3092\u767a\u73fe\u3059\u308b\u65b0\u898f\u767a\u5149Tg\u30de\u30a6\u30b9
\n<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n<\/div>\n

<\/a><\/p>\n

2023<\/h3>\n
\n
\n

Oct 2023
\n \u6642\u8a08\u907a\u4f1d\u5b50Bmal1<\/i>\u306e\u8ee2\u5199\u30ea\u30ba\u30e0\u5236\u5fa1\u30e1\u30ab\u30cb\u30ba\u30e0<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Sep 2023
\n \u30aa\u30ad\u30b7\u30c8\u30b7\u30f3\u53d7\u5bb9\u4f53(OXTR)\u6a5f\u80fd\u89e3\u6790\u30c4\u30fc\u30eb<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

July 2023
\n \u7740\u5e8a\u524d\u80da\u3067\u306e\u6027\u5225\u5224\u5b9a\u3092\u53ef\u80fd\u306b\u3059\u308b\u86cd\u5149\u30ec\u30dd\u30fc\u30bf\u30fc\u30de\u30a6\u30b9<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

May 2023
\n \u65b0\u898f\u30ab\u30eb\u30b7\u30a6\u30e0\u30bb\u30f3\u30b5\u30fcG-CaMP9a\u306b\u3088\u308b\u795e\u7d4c\u6d3b\u52d5in vivo<\/i>\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n<\/div>\n

\n
\n

Feb 2023
\n Gal4\/UAS\u767a\u73fe\u30b7\u30b9\u30c6\u30e0\u4f9d\u5b58\u7684\u306a\u907a\u4f1d\u5b50\u7d44\u307f\u63db\u3048\u3068\u7d30\u80de\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u304c\u53ef\u80fd\u306a\u30de\u30a6\u30b9<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Jan 2023
\n B\u7d30\u80de\u3067\u767a\u73fe\u3059\u308b
Cre\u30c9\u30e9\u30a4\u30d0\u30fc\u30de\u30a6\u30b9<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n<\/div>\n

<\/a><\/p>\n

2022<\/h3>\n
\n
\n

Nov 2022
\n RASopathies(RAS\/MAPK\u75c7\u5019\u7fa4)\u30e2\u30c7\u30eb\u30de\u30a6\u30b9<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Oct 2022
\n \u751f\u6b96\u7d30\u80de\u7cfb\u5217\u3067\u767a\u73fe\u3059\u308bCre\u30c9\u30e9\u30a4\u30d0\u30fc\u30de\u30a6\u30b9<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Aug 2022
\n \u30aa\u30ad\u30b7\u30c8\u30b7\u30f3\u7523\u751f\u30cb\u30e5\u30fc\u30ed\u30f3Cre\u30c9\u30e9\u30a4\u30d0\u30fc\u30de\u30a6\u30b9<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Jun 2022
\n \u304c\u3093\u7814\u7a76\u6ce8\u76ee\u306e\u56e0\u5b50Meflin(Islr)\u6a5f\u80fd\u89e3\u6790\u30c4\u30fc\u30eb<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n<\/div>\n

\n
\n

Apr 2022
\n \u91cd\u8907\u305b\u305a\u306b\u4e09\u80da\u8449\u3092\u86cd\u5149\u6a19\u8b58\u53ef\u80fd\u306aTRiCK<\/i>\u30de\u30a6\u30b9<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Mar 2022
\n \u6642\u7a7a\u9593\u7279\u7570\u7684\u907a\u4f1d\u5b50\u7d44\u307f\u63db\u3048\u3092\u53ef\u80fd\u306b\u3059\u308b\u65b0\u898fCre\u30c9\u30e9\u30a4\u30d0\u30fc\u30de\u30a6\u30b9<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Feb 2022
\n \u65b0\u898f\u30bf\u30f3\u30d1\u30af\u8cea\u30ce\u30c3\u30af\u30c0\u30a6\u30f3\u6280\u8853\u30aa\u30fc\u30ad\u30b7\u30f3\u30c7\u30b0\u30ed\u30f3(AID) 2\u6cd5<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n<\/div>\n

<\/a><\/p>\n

2021<\/h3>\n
\n
\n

Nov 2021
\n 3.0-Mb\u6b20\u5931\u3092\u518d\u73fe\u3057\u305f22q11.2\u6b20\u5931\u75c7\u5019\u7fa4\u30e2\u30c7\u30eb\u30de\u30a6\u30b9<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Oct 2021
\n \u65b0\u898f\u767d\u8cea\u6d88\u5931\u75c5\u30e2\u30c7\u30ebtoy\u30de\u30a6\u30b9<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Sep 2021
\n \u30de\u30a6\u30b9\u3067\u306e\u51ac\u7720\u69d8\u72b6\u614b\u306e\u8a98\u5c0e<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Aug 2021
\n \u5185\u8033\u7279\u7570\u7684\u306bGata3<\/i>\u907a\u4f1d\u5b50\u306e\u767a\u73fe\u3092\u5236\u5fa1\u3059\u308b\u30a8\u30f3\u30cf\u30f3\u30b5\u30fc\u914d\u5217Gata3<\/i> OVE<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n<\/div>\n

\n
\n

May 2021
\n \u52b9\u7387\u7684\u306a\u30b2\u30ce\u30e0\u7de8\u96c6\u30de\u30a6\u30b9\u4f5c\u88fd\u5b9f\u73fe\u306e\u305f\u3081\u958b\u767a\u3055\u308c\u305fCas9 Tg\u30de\u30a6\u30b9<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Mar 2021
\n \u67d3\u8272\u4f53\u5de5\u5b66\u6280\u8853\u3092\u7528\u3044\u3066\u4f5c\u88fd\u3055\u308c\u305f\u65b0\u898f\u30c0\u30a6\u30f3\u75c7\u5019\u7fa4\u30e2\u30c7\u30eb\u30de\u30a6\u30b9<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Feb 2021
\n Ucp1 in vivo<\/i>\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u30de\u30a6\u30b9<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n<\/div>\n

<\/a><\/p>\n

2020<\/h3>\n
\n
\n

Dec 2020
\n \u5149\u5909\u63db\u306b\u3088\u308a\u7d30\u80de\u52d5\u614b\u3092\u30e2\u30cb\u30bf\u30fc\u53ef\u80fd\u306aKaede\u30de\u30a6\u30b9<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Nov 2020
\n \u81ea\u7136\u514d\u75ab\u5fdc\u7b54\u3092\u5236\u5fa1\u3059\u308b\u8ee2\u5199\u56e0\u5b50\uff1aIRF3<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Mar 2020
\n \u30d1\u30a4\u30ed\u30c8\u30fc\u30b7\u30b9\u5b9f\u884c\u56e0\u5b50: \u30ac\u30b9\u30c0\u30fc\u30df\u30f3D<\/a><\/p>\n<\/div>\n

\n

Feb 2020
\n In vivo \u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u306b\u6709\u7528\u306a\u65b0\u898f\u30d8\u30a2\u30ec\u30b9\u30de\u30a6\u30b9<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n<\/div>\n

<\/a><\/p>\n

2019<\/h3>\n
\n
\n

Dec 2019
\n \u30b0\u30ea\u30b7\u30f3\u4f5c\u52d5\u6027\u30cb\u30e5\u30fc\u30ed\u30f3Cre\u30c9\u30e9\u30a4\u30d0\u30fc\u30de\u30a6\u30b9<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Nov 2019
\n ENU\u30df\u30e5\u30fc\u30bf\u30b8\u30a7\u30cd\u30b7\u30b9\u306b\u3088\u3063\u3066\u6a39\u7acb\u3055\u308c\u305fGLUT1\u6b20\u640d\u75c7\u30e2\u30c7\u30eb\u30de\u30a6\u30b9<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Oct 2019
\n \u7279\u5b9a\u30b2\u30ce\u30e0\u9818\u57df\u4e0a\u306e\u5206\u5b50\u9593\u76f8\u4e92\u4f5c\u7528\u89e3\u6790\u306b\u6709\u7528\u306a3xFLAG-dCas9\u767a\u73fe\u30de\u30a6\u30b9<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Aug 2019
\n \u9020\u8840\u5e79\u7d30\u80de\u306e\u81ea\u5df1\u8907\u88fd\u3092\u5236\u5fa1\u3059\u308bPHF6<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n<\/div>\n

\n
\n

Jul 2019
\n \u71b1\u30b9\u30c8\u30ec\u30b9\u5fdc\u7b54\u3060\u3051\u3067\u306a\u3044\u3001\u69d8\u3005\u306a\u5834\u9762\u3067\u6a5f\u80fd\u3059\u308b\u8ee2\u5199\u56e0\u5b50
Heat shock transcription factor 1 (HSF1)<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Jun 2019
\n \u8840\u53cb\u75c5B\u30e2\u30c7\u30eb\u30de\u30a6\u30b9<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Apr 2019
\n \u75db\u899a\u7570\u5e38\u3092\u793a\u3059Zfhx2<\/i>\u907a\u4f1d\u5b50\u6b20\u640d\u30de\u30a6\u30b9<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Mar 2019
\n Long-sleep mouse model induced by Sik3<\/i> splice mutation<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n<\/div>\n

\n
\n

Feb 2019
\n iRFP transgenic mice for in vivo<\/i> imaging<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Jan 2019
\n Bcl6 reporter mice for immune memory research<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n<\/div>\n

<\/a><\/p>\n

2018<\/h3>\n
\n
\n

Dec 2018
\nBicistronic Insulin1-Cre knock-in mice<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Nov 2018
\nAutism spectrum disorder (ASD) model mice<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Oct 2018
\nGreen-to-red fluorescent-convertible Cre-reporter mice<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n<\/div>\n

<\/a><\/p>\n

2017<\/h3>\n
\n
\n

Sep 2017
\nRAQP4, the main subset of the aquaporin water channel family in the brain<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Aug 2017
\nTranscranial imaging of intracellular Ca2+<\/SUP> in astrocytes and neurons<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Jun 2017
\nA tool for understanding endogenous sphingolipid synthesis<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Apr 2017
\nRegulatory function of nuclear protein I\u03baB-\u03b6 in inflammatory responses<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n<\/div>\n

\n
\n

Mar 2017
\nIdentifying pheromone circuits in mice<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Feb 2017
\nCell type-specific expression of photoconvertible fluorescent protein KikGR<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n<\/div>\n

<\/a><\/p>\n

2016<\/h3>\n
\n
\n

Oct 2016
\n Autophagy monitoring congenic strains<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Oct 2016
\n Atg7 deletion in various tissues<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Sep 2016
\n A new CreERT2 line for studying PDGFR\u03b1-expressing cells in vivo<\/i><\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Aug 2016
\n Monitoring cell replacement and migration in vivo<\/i> with Kaede<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n<\/div>\n

\n
\n

Jun 2016
\n Essjatial role of condensins I and II for early embryonic divisions in mice<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

May 2016
\n Impaired female fertility in Tinagl1<\/em> deficient mice<\/a><\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Apr 2016
\n Impaired female fertility in Tinagl1<\/em> deficient mice<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Mar 2016
\n A knock-in mouse strain with R124H human TGFBI mutationC<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n<\/div>\n

\n
\n

Feb 2016
\n Activation of NF-\u03baB pathway and suppression of cell death through linear polyubiquitination activity of LUBAC<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Jan 2016
\n Tracking and depletion of XCR1-positive dendritic cells<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n<\/div>\n

<\/a><\/p>\n

2015<\/h3>\n
\n
\n

Dec 2015
\nEstimating germline mutation rate in laboratory mouse<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Nov 2015
\nPathomechanistic model mice of sporadic ALS: Conditional ADAR2 knockout mice AR2<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Oct 2015
\nA tool for olfactory sensory neuron-specific mosaic analysis<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Sep 2015
\nOne-step generation of multiple transgenic mouse lines<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n<\/div>\n

\n
\n

Aug 2015
\n Multiple roles of Tetraspanin-interacting protein IGSF8<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Jul 2015
\n SIP1 expression patterns in the brain<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Jun 2015
\n Genetic tool for controlled G-CaMP7 expression in vivo<\/em><\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

May 2015
\n A key factor for epigenetic inheritance of DNA methylation<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n<\/div>\n

\n
\n

Apr 2015
\n Mouse model of human 15q11\u201313 duplication<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Feb 2015
\n Sirt1 overexpression in neural and vascular endothelial cells<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Jan 2015
\n Clarifying the role of Fbxw7 in cancer<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n<\/div>\n

<\/a><\/p>\n

2014<\/h3>\n
\n
\n

Dec 2014
\n CXCL12-abundant reticular cells as a microenvironmental niche in bone marrow<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Nov 2014
\n C429S mutation in the mouse \u03b2-catenin gene leads to infertility<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Oct 2014
\n A model mouse strain for Dravet syndrome<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Sep 2014
\n App<\/em> knock-in mouse strains: new models for Alzheimer’s disease<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n<\/div>\n

\n
\n

Aug 2014
\n Cell signaling of stress response via ASK1<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Jul 2014
\n Visualizing the neuronal activity-regulated gene Arc<\/em><\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Jun 2014
\n Conditional ablation of HMGB1 in mice<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

May 2014
\n Acquired A20 (Tnfaip3) deficiency in mice<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n<\/div>\n

\n
\n

Apr 2014
\n Targeted disruption of exon 52 in the dystrophin gene<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Mar 2014
\n Novel ROSA26 Cre-reporter knock-in C57BL\/6N mice<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Jan 2014
\n Fluorescent labeling of GABAergic neurons in the GAD67-GFP knock-in mouse<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n<\/div>\n

<\/a><\/p>\n

2013<\/h3>\n
\n
\n

Dec 2013
\n New reporter line for optogenetic stimulation at high frequencies<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Nov 2013
\n Skin abnormalities in mice lacking CD109<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Oct 2013
\n Lymphotoxin signaling in thymic organogenesis<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Sep 2013
\n Altered barrier integrity and enhanced sensitization by filaggrin deficiency<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n<\/div>\n

\n
\n

Aug 2013
\n Visualizing primordial germ cell development in mice<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Jul 2013
\nCre-mediated recombination in villus epithelial cells of the intestine<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Jun 2013
\n A tool for the conditional deletion of the transcriptional repressor Bcl6<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

May 2013
\n Regulating gene expression in photoreceptor precursor cells<\/p>\n

\"\"<\/a><\/p>\n<\/div>\n<\/div>\n

\n
\n

Apr 2013
\n Expanding the repertoire of optogenetic control<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Mar 2013
\n Cre reporter mouse expressing nuclear-localized beta-galactosidase<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Feb 2013
\n Multifunctional Rosa26 reporter mouse strain<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Jan 2013
\n Monitoring endoplasmic reticulum stress in mice<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n<\/div>\n

<\/p>\n

<\/a><\/p>\n

2012<\/h3>\n
\n
\n

Dec 2012
\n CD169+<\/sup>\u00a0macrophages in immune regulation<\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Nov\u00a02012
\n Metabolic impact of glucagon deficiency<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Oct 2012
\n A tool for the generation of germline-competent iPS cells<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Sep 2012
\n Critical roles of TRAF6<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n<\/div>\n

\n
\n

Aug 2012
\n Lethal anemia and chronic polyarthritis caused by undigested mammalian DNA<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Jul 2012
\n PD-1 deficiency and autoimmunity<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Jun 2012
\n Atg7 deletion in various tissues<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

May 2012
\n Renin-angiotensin system in hypertension<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n<\/div>\n

\n
\n

Apr 2012
\n Nrf2 in stress response and cancer development<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Mar 2012
\n Autophagy monitoring congenic strains<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Feb 2012
\n Green congenic mouse strains<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Jan 2012
\n A gene for central respiratory regulation<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n<\/div>\n

<\/p>\n

<\/a><\/p>\n

2011<\/h3>\n
\n
\n

Dec 2011
\n Neurodegeneration via endoplasmic reticulum stress<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Nov 2011
\n Hairless Congenics for Dermatology Studies<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Oct 2011
\n Visualizing Histone H2A Variants in Chromatin<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Sep 2011
\n TRPM1, a causative molecule for night blindness in retinal ON bipolar cells<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n<\/div>\n

\n
\n

Aug 2011
\n GP2 on M Cells for the Mucosal Immune Response<\/a><\/p>\n

\"\" <\/a><\/p>\n<\/div>\n

\n

Jul 2011
\n A Systemic Inflammation Model:Unc93B1 with a D34A mutation<\/a><\/p>\n

\"\" <\/a><\/p>\n<\/div>\n

\n

Jun 2011
\n A Dnmt1 knock-out mouse for epigenetic studies<\/a><\/p>\n

\"\" <\/a><\/p>\n<\/div>\n

\n

May 2011
\n Detecting Autophagy in the Heart<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n<\/div>\n

\n
\n

Apr 2011
\nA Conditional Lung Injury Model<\/a><\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Mar 2011
\nVisualizing neuronal activity<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n<\/div>\n

<\/p>\n

<\/a><\/p>\n

2010<\/h3>\n
\n
\n

Jul 2010
\n A model for retinitis pigmentosa (RP)<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n

\n

Jun 2010
\n A model for psychiatric disorder<\/a><\/p>\n

\"\"<\/a><\/p>\n<\/div>\n<\/div>\n

<\/p>\n

<\/p>\n

<\/a><\/p>\n\n\n\n\n\n<\/colgroup>\n\n\n\n\n\n
2009<\/td>\n<\/tr>\n
Oct 2009
\nDopamine receptor knockout mice<\/a> \"\"<\/a><\/td>\n		Sep 2009
\nSox2: An essential factor for maintaining neural stem cell<\/a> \"\"<\/a><\/td>\n		Aug 2009
\nVisualizing the Wnt signal pathway<\/a>
\n\"\"<\/a><\/td>\n		Jul 2009
\nAtg5: An essential molecule of autophagy<\/a> \"\"<\/a><\/td>\n<\/tr>\n
Jun 2009
\nC57BL\/6-Ly5 Antigen (Ptprc) Congenic Strains<\/a> <\/a><\/td>\n		May 2009
\nThe only one strain for study of NF-kB\/RelA subunit in vivo<\/a> \"\"<\/a><\/td>\n		Apr 2009
\nA Japanese wild-derived inbred strain for functional genomics<\/a> \"\"<\/a><\/td>\n		Mar 2009
\nFucci mice for visualizing cell-cycle in vivo<\/a> \"\"<\/a><\/td>\n<\/tr>\n
Feb 2009
\nThe Tsix\/Xist-deficient Strains<\/a> \"\"<\/a><\/td>\n		Jan 2009
\nBALB\/c Hbb Congenic Strains<\/a> \"\"<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/a><\/p>\n\n\n\n\n\n<\/colgroup>\n\n\n\n\n\n\n
2008<\/td>\n<\/tr>\n
Aug 2008
\nDelphilin KO Mouse<\/a><\/td>\n		Jul 2008
\nLck-p19Arf Transgenic Mouse<\/a><\/td>\n		Jun 2008
\nDrs KO Mouse<\/a><\/td>\n		May 2008
\nTH-GFP Transgenic Mouse<\/a><\/td>\n<\/tr>\n
\"\"<\/a><\/td>\n\"\"<\/a><\/td>\n\"\"<\/a><\/td>\n\"\"<\/a><\/td>\n<\/tr>\n
Apr 2008
\nPRAT4A KO Mouse<\/a><\/td>\n		Mar 2008
\nDisc1 Mutant Mouse<\/a><\/td>\n		Feb 2008
\nT-bet Transgenic Mouse<\/a><\/td>\n		Jan 2008
\nmDomino KO Mouse<\/a><\/td>\n<\/tr>\n
\"\"<\/a><\/td>\n\"\"<\/a><\/td>\n\"\"<\/a><\/td>\n\"\"\"\"<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/a><\/p>\n\n\n\n\n\n<\/colgroup>\n\n\n\n\n\n
2007<\/td>\n<\/tr>\n
Dec 2007
\nNanog-GFP Transgenic Mouse \"\"<\/a><\/td>\n		Nov 2007
\nEGFP-Akt Transgenic Mouse \"\"<\/a><\/td>\n		Oct 2007
\nDmp1-HBEGF Transgenic Mouse
\n\"\"\"\"\"\"\"\"<\/a><\/td>\n		Sep 2007
\nGdf5Rgsc451<\/sup> Mouse \"\"<\/a><\/td>\n<\/tr>\n
Aug 2007
\nK14-AhR-CA transgenic mice <\/a><\/td>\n		Jul 2007
\np38\u03b1 floxed mouse \"\"<\/a><\/td>\n		Jun 2007
\nCard15\/Nod2 KO mouse \"\"<\/a><\/td>\n		May 2007
\nLefty & Noda <\/a><\/td>\n<\/tr>\n
Apr 2007
\nKf-1 Knock-out Mouse \"\"<\/a><\/td>\n		Mar 2007
\nERAI transgenic mouse \"\"<\/a><\/td>\n		Feb 2007
\nFLPe transgenic mouse \"\"<\/a><\/td>\n		Jan 2007
\nRECS1 knockout mouse \"\"<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/a><\/p>\n\n\n\n\n\n<\/colgroup>\n\n\n\n\n\n
2006<\/td>\n<\/tr>\n
Dec 2006
\nMitfmi-bw<\/sup> mutant mouse \"\"<\/a><\/td>\n		Nov 2006
\nMFG-E8 KO mouse <\/a><\/td>\n		Oct 2006
\np27 KO mouse \"\"<\/a><\/td>\n		Sep 2006
\nThy1-SpH transgenic mouse
\n\"\"<\/a><\/td>\n<\/tr>\n
Aug 2006
\nSemaphorin III\/D gene targeting mice \"\"<\/a><\/td>\n		Jul 2006
\nCre Transgenic Mouse Series_2 \"\"<\/a><\/td>\n		Jun 2006
\nCre Transgenic Mouse\u00a0Series_1 \"\"\"\"\"\"<\/a><\/td>\n		May 2006
\nA model for bipolar disorder \"\"<\/a><\/td>\n<\/tr>\n
Apr 2006
\nHeparin-binding EGF-like growth factor (HB-EGF)-deficient mouse \"\"<\/a><\/td>\n		Mar 2006
\nt(7;11)AML\u539f\u56e0\u907a\u4f1d\u5b50NUP98-HOXA9 \"\"<\/a><\/td>\n		Feb 2006
\nMesp1:\u5fc3\u81d3\u5f62\u6210\u306e\u6c7a\u5b9a\u56e0\u5b50\u521d\u671f\u4e2d\u80da\u8449\u306e\u5f62\u6210\u6a5f\u69cb\u89e3\u660e\u306e\u30e2\u30c7\u30eb \"\"<\/a><\/td>\n		Jan 2006
\nA Model for Hyperlipidemia SHL: Spontaneous Mutation in the Apolipoprotein E gene \"\"<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/a><\/p>\n\n\n\n\n\n<\/colgroup>\n\n\n\n\n\n
2005<\/td>\n<\/tr>\n
Dec 2005
\nA Model for Type 2 Hyper-IgM\u00a0Syndrome \"\"<\/a><\/td>\n		Nov 2005
\nSMXA-RI Strains \"\"\"\"<\/a><\/td>\n		Oct 2005
\nNrf2 & Keap1
\n\"\"\"\"<\/a><\/td>\n		Sep 2005
\nVisualization of Primordial Germ Cells in Vivo \"\"<\/a><\/td>\n<\/tr>\n
Jun 2005
\nAnalysis of Rho\/Rho-kinase singnaling pathway \"\"<\/a><\/td>\n		Jun 2005
\nA Model for Tumor Biology: p53 KO mouse \"\"<\/a><\/td>\n		May 2005
\nA Model for Impaired Cytokine Secretion \"\"<\/a><\/td>\n		Apr 2005
\nA Model for Congenital Alopecia \"\"<\/a><\/td>\n<\/tr>\n
Mar 2005
\n\u81ea\u5df1\u514d\u75ab\u6027\u62e1\u5f35\u578b\u5fc3\u7b4b\u75c7\u30e2\u30c7\u30eb
\n\"\"<\/a><\/td>\n		Mar 2005
\n\u30aa\u30fc\u30c8\u30d5\u30a1\u30b8\u30fc\u691c\u51faGFP\u30e2\u30c7\u30eb
\n\"\"<\/a><\/td>\n		Mar 2005
\n\u4e73\u5150\u578b\u795e\u7d4c\u8ef8\u7d22\u30b8\u30b9\u30c8\u30ed\u30d5\u30a3\u30fc(INAD)\u30e2\u30c7\u30eb
\n\"\"<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

2026 Jun 2026 \u984e\u9854\u9762\u9aa8\u5f62\u6210\u4e0d\u5168\u75c7\u30e2\u30c7\u30eb\u30de\u30a6\u30b9 Apr 2026 \u30ec\u30e0\u7761\u7720\u306b\u95a2\u308f\u308bCrhbp\u907a\u4f1d\u5b50 2025 Apr 2025 Recql5 \u907a\u4f1d\u5b50\u5909\u7570\u30de\u30a6\u30b9\u3092\u7528\u3044\u305f\u67d3\u8272\u4f53\u65ad\u7247\u5316\u5f8c\u518d\u5408\u6210\u306e\u8a98\u767a 2024 Dec 2024 \u751f\u4f53\u5185\u30bf\u30f3\u30d1\u30af\u8cea\u9593\u76f8\u4e92\u4f5c\u7528\u3092\u89e3\u6790\u53ef\u80fd\u306ain vivo BioID\u30de\u30a6\u30b9 Apr 2024 CD103\u967d\u6027\u6a39\u72b6\u7d30\u80de\u3068\u6d88\u5316\u7ba1\u7c98\u819c\u514d\u75ab\u5bdb\u5bb9\u306e\u95a2\u4fc2\u6027 Mar 2024 \u65b0\u898f\u30d7 […]<\/p>\n","protected":false},"author":8,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_seopress_robots_follow":"","_seopress_robots_imageindex":"","_seopress_robots_snippet":"","_seopress_robots_primary_cat":"","_seopress_robots_breadcrumbs":"","_seopress_robots_freeze_modified_date":"","_seopress_robots_custom_modified_date":"","_seopress_robots_canonical":"","_seopress_social_fb_title":"","_seopress_social_fb_desc":"","_seopress_social_fb_img":"","_seopress_social_fb_img_attachment_id":0,"_seopress_social_fb_img_width":0,"_seopress_social_fb_img_height":0,"_seopress_social_twitter_title":"","_seopress_social_twitter_desc":"","_seopress_social_twitter_img":"","_seopress_social_twitter_img_attachment_id":0,"_seopress_social_twitter_img_width":0,"_seopress_social_twitter_img_height":0,"_seopress_redirections_value":"","_seopress_redirections_enabled":"","_seopress_redirections_enabled_regex":"","_seopress_redirections_logged_status":"both","_seopress_redirections_param":"","_seopress_redirections_type":301,"_seopress_analysis_target_kw":"","footnotes":"","_wp_rev_ctl_limit":""},"class_list":["post-198","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"http:\/\/mus.brc.riken.jp\/ja\/wp-json\/wp\/v2\/pages\/198","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/mus.brc.riken.jp\/ja\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"http:\/\/mus.brc.riken.jp\/ja\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"http:\/\/mus.brc.riken.jp\/ja\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"http:\/\/mus.brc.riken.jp\/ja\/wp-json\/wp\/v2\/comments?post=198"}],"version-history":[{"count":22,"href":"http:\/\/mus.brc.riken.jp\/ja\/wp-json\/wp\/v2\/pages\/198\/revisions"}],"predecessor-version":[{"id":21051,"href":"http:\/\/mus.brc.riken.jp\/ja\/wp-json\/wp\/v2\/pages\/198\/revisions\/21051"}],"wp:attachment":[{"href":"http:\/\/mus.brc.riken.jp\/ja\/wp-json\/wp\/v2\/media?parent=198"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}